Orally active salts with tyrosine kinase activity

Details for Australian Patent Application No. 2002226877 (hide)

Owner Merck & Co., Inc.

Inventors Kim, Yuntae; Karki, Shyam B.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2002226877

PCT Pub. Number WO02/32861

Priority 60/241,043 17.10.00 US

Filing date 17 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 12 January 2006

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 243/06 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 January 2006 Application Accepted

  Published as AU-B-2002226877

11 May 2006 Standard Patent Sealed

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002226878-DISPLAY SIGN MOUNTING SYSTEM

2002226876